Syncom Formulations India Ltd KYS Report: Ownership & Insights | Research 360

15:59 Dec 12

Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

14.92

-0.03 (-0.20%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

14.92

-0.03 (-0.20%)

86/100 High Financial Strength

Quality

44/100 Mid Valuation

Valuation

32/100 Technically Bearish

Technical

SWOT

Strength

10

Weakness

4

Opportunity

0

Threat

0

1.40K

Market Cap (Cr)

22.24

PE Ratio

3.71

Price to Book Ratio

31.35

RSI

10.63 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password